Roche launches three new Factor Xa inhibitor coagulation tests to meet growing patient need

Roche Denmark Finland France Germany Netherlands Sweden United Kingdom Switzerland

The new tests can support clinical decision making when prescribing direct oral anticoagulants for stroke prevention Increased testing is needed to meet growing demand since these anticoagulants were added to the WHO list of essential medicinesThe new assays will utilise Roche's reagent cassette concept, ensuring high quality results and efficient sample processing
[3] National Library of Medicine [internet; cited 2024, Jan 30] Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2787400/
[4] National Library of Medicine [internet; cited 2024, Jan 30] Available from: https://www.ncbi.nlm.nih.gov/books/NBK430745/

For further information please contact

Jonathan Parry, Roche Diagnostics Solutions
Phone: + 41 79 653 76 43
e-Mail: [e-mail]

View original content:https://www.prnewswire.co.uk/news-releases/roche-launches-three-new-factor-xa-inhibitor-coagulation-tests-to-meet-growing-patient-need-302058718.html